Evidence map›Paper›PMID 39022321›Full record

ArticleWellcome open research2024

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.

Le Nguyen Truc Nhu, Mary Chambers, Narisara Chantratita, Phaik Yeong Cheah, Nicholas P J Day, Wanwisa Dejnirattisai, Susanna J Dunachie, Alba Grifoni, Raph L Hamers, Jennifer Hill and 12 more

Abstract read
In one paragraph

Article in Wellcome open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Le Nguyen Truc NhuOxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.ORCID https://orcid.org/0000-0002-7685-9730
Mary ChambersOxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.ORCID https://orcid.org/0000-0003-0535-3895
Narisara ChantratitaDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Phaik Yeong CheahCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0001-6327-3266
Nicholas P J DayCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0003-2309-1171
Wanwisa DejnirattisaiDivision of Emerging Infectious Disease, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Susanna J DunachieDivision of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0001-5665-6293
Alba GrifoniLa Jolla Institute for Immunology, San Diego, California, USA.
Raph L HamersCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.
Jennifer HillDivision of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0001-6205-7764
E Yvonne JonesDivision of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.
Paul KlenermanDivision of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.ORCID https://orcid.org/0000-0003-4307-9161
Juthathip MongkolsapayaDepartment of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Gavin ScreatonChinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, England, UK.
Alessandro SetteLa Jolla Institute for Immunology, San Diego, California, USA.
David I StuartDivision of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, England, UK.
Chee Wah TanProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
Guy ThwaitesOxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.ORCID https://orcid.org/0000-0002-2858-2087
Vu Duy ThanhOxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.
Lin-Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.
Le Van TanOxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.ORCID https://orcid.org/0000-0002-1791-3901
SEACOVARIANTS Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time. Many countries in Southeast Asia lack capacity to determine the potential threat of new variants, or other emerging infections. Funded by Wellcome, the Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium aims to develop and apply a multidisciplinary research platform in Southeast Asia (SEA) for rapid assessment of the biological significance of SARS-CoV-2 variants, thereby informing coordinated local, regional and global responses to the COVID-19 pandemic. Our proposal is delivered by the Vietnam and Thailand Wellcome Africa Asia Programmes, bringing together a multidisciplinary team in Indonesia, Thailand and Vietnam with partners in Singapore, the UK and the USA. Herein we outline five work packages to deliver strengthened regional scientific capacity that can be rapidly deployed for future outbreak responses.

Indexed as

pandemic responsesSARS-CoV-2 variants

Identifiers

PMID39022321
PMCPMC11252647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.